Plain-English translation of NCT06307262 on ClinicalTrials.gov β Β· Source last updated Β· Translation generated Β· How we translate trials
The EuroTR registry is collecting data from patients who have received one of several new transcatheter devices (PASCAL, TriClip, TricValve, Evoque, or LuX-Valve) to repair or replace a leaky tricuspid valve β a valve on the right side of the heart. Researchers are tracking how well these minimally invasive treatments work and what happens to patients after the procedure, using real-world information gathered across Europe.
Tricuspid regurgitation β a condition where the heart's tricuspid valve leaks β causes serious problems like heart failure hospitalizations and can be life-threatening. Traditional open-heart surgery to fix this valve carries very high risks, leaving many patients without treatment options. This new minimally invasive approach offers hope, but doctors need to better understand which patients benefit most and how well these treatments work over time.
You likely qualify ifβ¦
You likely don't qualify ifβ¦
If you join this registry, you are agreeing to have your medical information β including details about your procedure, recovery, and long-term health outcomes β collected and stored in a European database for research purposes. You may be contacted for follow-up information about your health status at various time points after your treatment. There is no new medication or additional procedures required; this is purely about sharing your existing medical records and outcomes data.
AI-generated summary from trial data Β· Jun 5, 2026 Β· Not medical advice
Germany
Sponsor
LMU Klinikum
Enrollment target
~3,000 participants
Started
October 2023
Primary completion
December 2030
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2024.
Reach out to the team running this trial. Response times vary β some teams are faster than others.
Central contact
JΓΆrg Hausleiter, Prof. Dr.
LMU Klinikum
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first β no email needed to get started.